NewGenIvf (NIVF) Gross Profit (2024 - 2025)
NewGenIvf (NIVF) reported Gross Profit of $524025.0 for Q4 2025, down 2.8% year-over-year from $539135.0 in Q4 2024, and up 344.03% quarter-over-quarter from $118017.0 in Q3 2025.
NewGenIvf (NIVF) Gross Profit (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has 2 years of Gross Profit data on file, last reported at $524025.0 in Q4 2025.
- Gross Profit for Q4 2025 came in at $524025.0, down 2.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.8 million (changed N/A YoY), and the FY2025 annual result was $955846.0, down 47.68% from the prior year.
- Gross Profit advanced to $524025.0 in Q4 2025 per NIVF's latest filing, from $118017.0 in the prior quarter.
- Over five years, Gross Profit peaked at $649077.0 in Q3 2024 and troughed at $118017.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | NewGenIvf | - | - | 524,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 524,025.00 |
| Dec 31, 2025 | 524,025.00 |
| Sep 30, 2025 | 118,017.00 |
| Sep 30, 2025 | 118,017.00 |
| Dec 31, 2024 | 539,135.00 |
| Dec 31, 2024 | 539,135.00 |
| Sep 30, 2024 | 649,077.00 |
| Sep 30, 2024 | 649,077.00 |